# A Multicenter Extension Trial to Evaluate the Safety of Testosterone Gel

> **NCT01703741** · PHASE3 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 145 (actual)

## Conditions studied

- Adult Male Hypogonadism

## Interventions

- **DRUG:** Testosterone Gel (FE 999093)

## Key facts

- **NCT ID:** NCT01703741
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 145 (ACTUAL)
- **Last updated:** 2017-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01703741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01703741, "A Multicenter Extension Trial to Evaluate the Safety of Testosterone Gel". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01703741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*